HEADER IMMUNE SYSTEM 21-DEC-11 3V7M TITLE CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 TITLE 2 T125(YB2/0) IN THE PRESENCE OF ZN2+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 119-327; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: RATTUS NORVEGICUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: RAT; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10116; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: (ATCC, CRL-1662) [T125(YB2/0)]; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: CMV PROMOTER; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCI-NEO KEYWDS FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.MENEZ,E.A.STURA,D.BOUREL,S.SIBERIL,S.JORIEUX,C.DE ROMEUF, AUTHOR 2 F.DUCANCEL,W.H.FRIDMAN,J.L.TEILLAUD REVDAT 5 13-SEP-23 3V7M 1 HETSYN REVDAT 4 29-JUL-20 3V7M 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 08-OCT-14 3V7M 1 AUTHOR REVDAT 2 28-AUG-13 3V7M 1 JRNL REVDAT 1 22-FEB-12 3V7M 0 JRNL AUTH S.SIBERIL,R.MENEZ,S.JORIEUX,C.DE ROMEUF,D.BOUREL, JRNL AUTH 2 W.H.FRIDMAN,F.DUCANCEL,E.A.STURA,J.L.TEILLAUD JRNL TITL EFFECT OF ZINC ON HUMAN IGG1 AND ITS FC GAMMA R JRNL TITL 2 INTERACTIONS. JRNL REF IMMUNOL.LETT. V. 143 60 2012 JRNL REFN ISSN 0165-2478 JRNL PMID 22553781 REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 16796 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 884 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.02 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 REFLECTION IN BIN (WORKING SET) : 803 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3210 REMARK 3 BIN FREE R VALUE SET COUNT : 42 REMARK 3 BIN FREE R VALUE : 0.3630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1669 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 142 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.13000 REMARK 3 B22 (A**2) : -0.45000 REMARK 3 B33 (A**2) : 1.58000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.222 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.199 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.155 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.625 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1843 ; 0.022 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2518 ; 2.136 ; 2.034 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 208 ; 7.136 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 75 ;34.152 ;24.933 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 289 ;22.107 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;20.147 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 297 ; 0.154 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1343 ; 0.010 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1053 ; 1.465 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1731 ; 2.576 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 790 ; 3.185 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 787 ; 4.963 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3V7M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-DEC-11. REMARK 100 THE DEPOSITION ID IS D_1000069696. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17681 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 18.8100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.62 REMARK 200 R MERGE FOR SHELL (I) : 0.75900 REMARK 200 R SYM FOR SHELL (I) : 0.71200 REMARK 200 FOR SHELL : 2.710 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2J6E FC PORTION ONLY. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% MPEG 5000, 300 MICRO-M ZNCL2, 100 REMARK 280 MICRO-M NICL2, 0.1 M SODIUM CACODYLATE, PH 5.1, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 316KK REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.77000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.77000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 25.11000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 73.87500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 25.11000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 73.87500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.77000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 25.11000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 73.87500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.77000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 25.11000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 73.87500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -114.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 37.77000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 686 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN A 311 CB GLN A 311 CG -0.162 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 291 109.54 -37.57 REMARK 500 ARG A 292 143.30 -36.59 REMARK 500 ALA A 327 -18.17 -45.13 REMARK 500 ASN A 384 49.96 38.51 REMARK 500 ASN A 390 60.33 -101.61 REMARK 500 GLN A 419 -5.31 -55.73 REMARK 500 ASN A 421 156.43 -45.39 REMARK 500 ASN A 434 19.83 57.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 510 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 285 ND1 REMARK 620 2 IMD A 512 N3 96.4 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 509 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 310 NE2 REMARK 620 2 HIS A 435 NE2 105.8 REMARK 620 3 IMD A 513 N1 120.8 101.5 REMARK 620 4 IMD A 514 N3 114.5 97.3 112.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 511 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 433 ND1 REMARK 620 2 HOH A 733 O 140.3 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3FJT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED REMARK 900 SERUM HALF-LIFE REMARK 900 RELATED ID: 2J6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM REMARK 900 RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND REMARK 900 EVIDENCE FOR AFFINITY MATURATION REMARK 900 RELATED ID: 3D6G RELATED DB: PDB REMARK 900 FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE REMARK 900 DENDRIMER LIGAND. REMARK 900 RELATED ID: 3V8C RELATED DB: PDB DBREF 3V7M A 236 444 UNP P01857 IGHG1_HUMAN 119 327 SEQRES 1 A 209 GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS SEQRES 2 A 209 ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS SEQRES 3 A 209 VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS SEQRES 4 A 209 PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA SEQRES 5 A 209 LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR SEQRES 6 A 209 ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP SEQRES 7 A 209 LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS SEQRES 8 A 209 ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA SEQRES 9 A 209 LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO SEQRES 10 A 209 PRO SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU SEQRES 11 A 209 THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA SEQRES 12 A 209 VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR SEQRES 13 A 209 LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE SEQRES 14 A 209 PHE LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP SEQRES 15 A 209 GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU SEQRES 16 A 209 ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SEQRES 17 A 209 SER MODRES 3V7M ASN A 297 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET MAN B 3 11 HET MAN B 4 11 HET NAG B 5 14 HET GAL B 6 11 HET MAN B 7 11 HET NAG B 8 14 HET ZN A 509 1 HET ZN A 510 1 HET ZN A 511 1 HET IMD A 512 5 HET IMD A 513 5 HET IMD A 514 5 HET GOL A 515 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM ZN ZINC ION HETNAM IMD IMIDAZOLE HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 NAG 4(C8 H15 N O6) FORMUL 2 MAN 3(C6 H12 O6) FORMUL 2 GAL C6 H12 O6 FORMUL 3 ZN 3(ZN 2+) FORMUL 6 IMD 3(C3 H5 N2 1+) FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *142(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 LYS A 360 5 7 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 ASN A 434 5 3 SHEET 1 A 4 SER A 239 PHE A 243 0 SHEET 2 A 4 GLU A 258 VAL A 266 -1 O VAL A 264 N SER A 239 SHEET 3 A 4 TYR A 300 THR A 307 -1 O SER A 304 N CYS A 261 SHEET 4 A 4 LYS A 288 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 B 4 SER A 239 PHE A 243 0 SHEET 2 B 4 GLU A 258 VAL A 266 -1 O VAL A 264 N SER A 239 SHEET 3 B 4 TYR A 300 THR A 307 -1 O SER A 304 N CYS A 261 SHEET 4 B 4 GLU A 293 GLU A 294 -1 N GLU A 293 O ARG A 301 SHEET 1 C 4 VAL A 282 VAL A 284 0 SHEET 2 C 4 LYS A 274 VAL A 279 -1 N TRP A 277 O VAL A 284 SHEET 3 C 4 TYR A 319 SER A 324 -1 O LYS A 322 N ASN A 276 SHEET 4 C 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 D 4 GLN A 347 LEU A 351 0 SHEET 2 D 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 D 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 D 4 TYR A 391 THR A 393 -1 N LYS A 392 O LYS A 409 SHEET 1 E 4 GLN A 347 LEU A 351 0 SHEET 2 E 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 E 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 E 4 VAL A 397 LEU A 398 -1 N VAL A 397 O PHE A 405 SHEET 1 F 4 GLN A 386 PRO A 387 0 SHEET 2 F 4 ALA A 378 SER A 383 -1 N SER A 383 O GLN A 386 SHEET 3 F 4 PHE A 423 MET A 428 -1 O SER A 424 N GLU A 382 SHEET 4 F 4 TYR A 436 LEU A 441 -1 O LEU A 441 N PHE A 423 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.06 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.06 LINK ND2 ASN A 297 C1 NAG B 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.45 LINK O4 NAG B 2 C1 MAN B 3 1555 1555 1.42 LINK O6 MAN B 3 C1 MAN B 4 1555 1555 1.43 LINK O3 MAN B 3 C1 MAN B 7 1555 1555 1.44 LINK O2 MAN B 4 C1 NAG B 5 1555 1555 1.41 LINK O4 NAG B 5 C1 GAL B 6 1555 1555 1.43 LINK O2 MAN B 7 C1 NAG B 8 1555 1555 1.45 LINK ND1 HIS A 285 ZN ZN A 510 1555 1555 2.29 LINK NE2 HIS A 310 ZN ZN A 509 1555 1555 2.04 LINK ND1 HIS A 433 ZN ZN A 511 1555 1555 1.72 LINK NE2 HIS A 435 ZN ZN A 509 1555 1555 2.18 LINK ZN ZN A 509 N1 IMD A 513 1555 1555 2.30 LINK ZN ZN A 509 N3 IMD A 514 1555 1555 2.12 LINK ZN ZN A 510 N3 IMD A 512 1555 1555 1.69 LINK ZN ZN A 511 O HOH A 733 1555 1555 2.51 CISPEP 1 TYR A 373 PRO A 374 0 -1.96 CRYST1 50.220 147.750 75.540 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019912 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006768 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013238 0.00000